GLUT-1 expression is regulated by HIF-1α and the PI3K/Akt signaling pathway.39 Hafner et al (2012)37 found that the PI3K/AKT pathway was activated in patients with Merkel cell carcinoma and suggested that the pathway may represent a useful new therapeutic target. The gene discussed is SLC2A1; the disease is Merkel cell skin cancer.